{"DataElement":{"publicId":"2179727","version":"2","preferredName":"Head and Neck Tumor Histologic Category","preferredDefinition":"information related to the histologic classification or category of a head and neck tumor.","longName":"HDNCK_TUMOR_HIST_CAT","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2195124","version":"1","preferredName":"Head and Neck Tumor Histologic Classification","preferredDefinition":"information related to the histologic classification or category of a head and neck tumor.","longName":"HDNCK_TUM_HIST_CLASS","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2228482","version":"1","preferredName":"Head and Neck Neoplasm","preferredDefinition":"For oncology, area of the body generally construed to comprise base of skull and facial bones, sinuses, orbits, salivary glands, oral cavity, oropharynx, larynx, thyroid, facial and neck musculature and lymph nodes draining these areas.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12418:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Head and Neck","conceptCode":"C12418","definition":"For oncology, an area of the body generally construed to comprise the base of skull and facial bones, sinuses, orbits, salivary glands, oral cavity, oropharynx, larynx, thyroid, facial and neck musculature and lymph nodes draining these areas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F6EF4E2B-72AC-72C1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-05-12","modifiedBy":"ONEDATA","dateModified":"2005-05-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207691","version":"1","preferredName":"Histologic Classification","preferredDefinition":"Of or relating to histology.:Classification; the grouping of things into classes or categories.","longName":"C25526:C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-2C90-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ED053B9F-B4D1-0BAE-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-01-06","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-01-06","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2179726","version":"2","preferredName":"Head and Neck Tumor Histologic Category","preferredDefinition":"the structural pattern of cancer cells used to define a diagnosis for head and neck cancer.","longName":"HDNCK_TUMOR_HIST_CAT","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"75","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Carcinoma in situ","valueDescription":"Carcinoma in situ (specify histologic type)","ValueMeaning":{"publicId":"2567896","version":"1","preferredName":"Carcinoma in situ (specify histologic type)","longName":"2567896","preferredDefinition":"Carcinoma in situ (specify histologic type)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D645-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-02","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6A49CC4-F907-454C-E053-4EBD850A4E2E","beginDate":"2004-01-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"Nonkeratinizing Carcinoma differentiated","valueDescription":"Nasopharyngeal Nonkeratinizing Carcinoma Cell Differentiation Process","ValueMeaning":{"publicId":"4045371","version":"1","preferredName":"Nasopharyngeal Nonkeratinizing Carcinoma Cell Differentiation Process","longName":"4045371","preferredDefinition":"A nasopharyngeal carcinoma characterized by the lack of keratinization and the presence of a dense lymphoplasmacytic infiltrate.  It is subdivided into undifferentiated and differentiated types, based on the cytologic features of the malignant cells.  The undifferentiated type is characterized by the presence of cells with large vesicular nuclei with prominent nucleoli and a syncytial pattern of growth.  The differentiated type is characterized by the presence of smaller cells and cellular stratification reminiscent of transitional cell carcinoma.  While morphologically distinct, both types have similar clinical presentation and prognosis.: Progressive restriction of the developmental potential and increasing specialization of function which takes place during the development of the embryo and leads to the formation of specialized cells, tissues, and organs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nasopharyngeal Non-Keratinizing Carcinoma","conceptCode":"C7373","definition":"A nasopharyngeal carcinoma characterized by the lack of keratinization and the presence of a dense lymphoplasmacytic infiltrate.  It is subdivided into undifferentiated and differentiated types, based on the cytologic features of the malignant cells.  The undifferentiated type is characterized by the presence of cells with large vesicular nuclei with prominent nucleoli and a syncytial pattern of growth.  The differentiated type is characterized by the presence of smaller cells and cellular stratification reminiscent of transitional cell carcinoma.  While morphologically distinct, both types have similar clinical presentation and prognosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cell Differentiation Process","conceptCode":"C16399","definition":"Progressive restriction of the developmental potential and increasing specialization of function which takes place during the development of the embryo and leads to the formation of specialized cells, tissues, and organs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EF4FAD38-BB6A-3C70-E040-BB89AD43049C","latestVersionIndicator":"Yes","beginDate":"2014-01-06","endDate":null,"createdBy":"RUETERJ","dateCreated":"2014-01-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6A49CC4-FABA-454C-E053-4EBD850A4E2E","beginDate":"2014-01-06","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"Squamous cell carcinoma including variants","valueDescription":"Squamous cell carcinoma, including variants","ValueMeaning":{"publicId":"2572562","version":"1","preferredName":"Squamous cell carcinoma, including variants","longName":"2572562","preferredDefinition":"Squamous cell carcinoma, including variants","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E87F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-12-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-12-29","modifiedBy":"CAMPBELB","dateModified":"2004-12-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6A49CC4-FAE2-454C-E053-4EBD850A4E2E","beginDate":"2004-12-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"Verrucous squamous cell carcinoma","valueDescription":"Verrucous squamous cell carcinoma","ValueMeaning":{"publicId":"2567899","version":"1","preferredName":"Verrucous squamous cell carcinoma","longName":"2567899","preferredDefinition":"Verrucous squamous cell carcinoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D648-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-02","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6A49CC4-F925-454C-E053-4EBD850A4E2E","beginDate":"2004-01-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"Adenoid squamous cell carcinoma","valueDescription":"Adenoid squamous cell carcinoma","ValueMeaning":{"publicId":"2567900","version":"1","preferredName":"Adenoid squamous cell carcinoma","longName":"2567900","preferredDefinition":"Adenoid squamous cell carcinoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D649-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-02","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6A49CC4-F92F-454C-E053-4EBD850A4E2E","beginDate":"2004-01-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"Basaloid squamous cell carcinoma","valueDescription":"Basaloid squamous cell carcinoma","ValueMeaning":{"publicId":"2567901","version":"1","preferredName":"Basaloid squamous cell carcinoma","longName":"2567901","preferredDefinition":"Basaloid squamous cell carcinoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D64A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-02","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6A49CC4-F939-454C-E053-4EBD850A4E2E","beginDate":"2004-01-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"Adenosquamous carcinoma","valueDescription":"ADENOSQUAMOUS CARCINOMA","ValueMeaning":{"publicId":"2558186","version":"1","preferredName":"ADENOSQUAMOUS CARCINOMA","longName":"2558186v1.00","preferredDefinition":"An invasive carcinoma composed of malignant glandular cells and malignant squamous cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenosquamous Carcinoma","conceptCode":"C3727","definition":"An invasive carcinoma composed of malignant glandular cells and malignant squamous cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B057-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"KUMMEROA","dateModified":"2023-08-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6A49CC4-F943-454C-E053-4EBD850A4E2E","beginDate":"2002-08-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"Adenocarcinoma","valueDescription":"Adenocarcinoma","ValueMeaning":{"publicId":"2567203","version":"1","preferredName":"Adenocarcinoma","longName":"2567203","preferredDefinition":"A common cancer characterized by the presence of malignant glandular cells. Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous). Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D390-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6A49CC4-F94D-454C-E053-4EBD850A4E2E","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"Spindle cell carcinoma","valueDescription":"Spindle cell carcinoma","ValueMeaning":{"publicId":"2567902","version":"1","preferredName":"Spindle cell carcinoma","longName":"2567902","preferredDefinition":"Spindle cell carcinoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D64B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-02","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6A49CC4-F957-454C-E053-4EBD850A4E2E","beginDate":"2004-01-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"Acinic cell carcinoma","valueDescription":"Acinic cell carcinoma","ValueMeaning":{"publicId":"2567903","version":"1","preferredName":"Acinic cell carcinoma","longName":"2567903","preferredDefinition":"Acinic cell carcinoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D64C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-02","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6A49CC4-F961-454C-E053-4EBD850A4E2E","beginDate":"2004-01-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"Mucoepidermoid carcinoma","valueDescription":"Mucoepidermoid carcinoma","ValueMeaning":{"publicId":"2567904","version":"1","preferredName":"Mucoepidermoid carcinoma","longName":"2567904","preferredDefinition":"Mucoepidermoid carcinoma","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mucoepidermoid Carcinoma","conceptCode":"C3772","definition":"A carcinoma morphologically characterized the presence of cuboidal mucous cells, goblet-like mucous cells, squamoid cells, cystic changes, and a fibrotic stromal formation. It can occur in several anatomic sites, including parotid gland, oral cavity, paranasal sinus, skin, breast, lung, larynx, and lacrimal ducts. It is classified as low or high grade.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D64D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-02","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6A49CC4-F96B-454C-E053-4EBD850A4E2E","beginDate":"2004-01-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"Adenoid cystic carcinoma","valueDescription":"Adenoid cystic carcinoma","ValueMeaning":{"publicId":"2567905","version":"1","preferredName":"Adenoid cystic carcinoma","longName":"2567905","preferredDefinition":"A malignant tumor arising from the epithelial cells. Microscopically, the neoplastic epithelial cells form cylindrical spatial configurations (cribriform or classic type of adenoid cystic carcinoma), cordlike structures (tubular type of adenoid cystic carcinoma), or solid structures (basaloid variant of adenoid cystic carcinoma). Adenoid cystic carcinomas mostly occur in the salivary glands. Other primary sites of involvement include the lacrimal gland, the larynx, and the lungs. Adenoid cystic carcinomas spread along nerve sheaths, resulting in severe pain, and they tend to recur. Lymph node metastases are unusual; hematogenous tumor spread is characteristic.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenoid Cystic Carcinoma","conceptCode":"C2970","definition":"A malignant tumor arising from the epithelial cells.  Microscopically, the neoplastic epithelial cells form cylindrical spatial configurations (cribriform or classic type of adenoid cystic carcinoma), cordlike structures (tubular type of adenoid cystic carcinoma), or solid structures (basaloid variant of adenoid cystic carcinoma).  Adenoid cystic carcinomas mostly occur in the salivary glands.  Other primary sites of involvement include the lacrimal gland, the larynx, and the lungs.  Adenoid cystic carcinomas spread along nerve sheaths, resulting in severe pain, and they tend to recur.  Lymph node metastases are unusual; hematogenous tumor spread is characteristic.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D64E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-02","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6A49CC4-F975-454C-E053-4EBD850A4E2E","beginDate":"2004-01-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"Carcinoma in pleomorphic adenoma","valueDescription":"Carcinoma in pleomorphic adenoma","ValueMeaning":{"publicId":"2567906","version":"1","preferredName":"Carcinoma in pleomorphic adenoma","longName":"2567906","preferredDefinition":"Carcinoma in pleomorphic adenoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D64F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-02","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6A49CC4-F97F-454C-E053-4EBD850A4E2E","beginDate":"2004-01-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"Epithelial-myoepithelial carcinoma","valueDescription":"Epithelial-myoepithelial carcinoma","ValueMeaning":{"publicId":"2567907","version":"1","preferredName":"Epithelial-myoepithelial carcinoma","longName":"2567907","preferredDefinition":"Epithelial-myoepithelial carcinoma","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epithelial-Myoepithelial Carcinoma","conceptCode":"C4199","definition":"A malignant neoplasm which occurs mostly in the major salivary glands (most frequently in the parotid gland), but also in the minor salivary glands of the oral mucosa and the tracheobronchial tree. It is characterized by the presence of ductal structures which are lined by an inner layer of cuboidal epithelial-type cells and an outer layer of myoepithelial cells with clear or eosinophilic cytoplasm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D650-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-02","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6A49CC4-F989-454C-E053-4EBD850A4E2E","beginDate":"2004-01-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"Clear cell carcinoma","valueDescription":"CLEAR CELL CARCINOMA","ValueMeaning":{"publicId":"2558510","version":"1","preferredName":"CLEAR CELL CARCINOMA","longName":"2558510","preferredDefinition":"CLEAR CELL CARCINOMA","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B19B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6A49CC4-F993-454C-E053-4EBD850A4E2E","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"Giant cell carcinoma","valueDescription":"Giant cell carcinoma","ValueMeaning":{"publicId":"2567908","version":"1","preferredName":"Giant cell carcinoma","longName":"2567908","preferredDefinition":"Giant cell carcinoma","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Giant Cell Carcinoma","conceptCode":"C3779","definition":"A malignant epithelial neoplasm composed of giant, pleomorphic cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D651-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-02","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6A49CC4-F99D-454C-E053-4EBD850A4E2E","beginDate":"2004-01-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"Small cell carcinoma","valueDescription":"Small cell carcinoma","ValueMeaning":{"publicId":"2567204","version":"1","preferredName":"Small cell carcinoma","longName":"2567204","preferredDefinition":"A neuroendocrine carcinoma composed of small malignant cells which are often said to resemble \"oat cells\" under the microscope.  Small cell carcinoma most often affects the lungs.  Clinically, this is often a rapidly growing cancer that spreads to distant sites early.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Small Cell Neuroendocrine Carcinoma","conceptCode":"C3915","definition":"An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation. It is composed of malignant small cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D391-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"REEVESD","dateModified":"2016-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6A49CC4-F9A7-454C-E053-4EBD850A4E2E","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"Salivary duct carcinoma","valueDescription":"Salivary duct carcinoma","ValueMeaning":{"publicId":"2567909","version":"1","preferredName":"Salivary duct carcinoma","longName":"2567909","preferredDefinition":"Salivary duct carcinoma","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Salivary Duct Carcinoma","conceptCode":"C5904","definition":"An aggressive, high grade adenocarcinoma that arises from the salivary glands. It usually affects elderly males and presents as a rapidly enlarging mass. It metastasizes to regional lymph nodes and distant anatomic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D652-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-02","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6A49CC4-F9B1-454C-E053-4EBD850A4E2E","beginDate":"2004-01-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"Carcinoid tumor","valueDescription":"Carcinoid tumor","ValueMeaning":{"publicId":"2567910","version":"1","preferredName":"Carcinoid tumor","longName":"2567910","preferredDefinition":"Carcinoid tumor","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Carcinoid Tumor","conceptCode":"C2915","definition":"A slow growing neuroendocrine tumor, composed of uniform, round, or polygonal cells having monotonous, centrally located nuclei and small nucleoli, infrequent mitoses, and no necrosis.  The tumor may show a variety of patterns, such as solid, trabecular, and acinar.  Electron microscopy shows small secretory granules.  Immunohistochemical studies reveal NSE, as well as chromogranin immunoreactivity.  Malignant histology (cellular pleomorphism, hyperchromatic nuclei, prominent nucleoli, necrosis, and mitoses) can occasionally be seen.  Such cases may have an aggressive clinical course.  Gastrointestinal tract and lung are common sites of involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D653-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-02","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6A49CC4-F9BB-454C-E053-4EBD850A4E2E","beginDate":"2004-01-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"Atypical carcinoid tumor","valueDescription":"Atypical carcinoid tumor","ValueMeaning":{"publicId":"2567911","version":"1","preferredName":"Atypical carcinoid tumor","longName":"2567911v1.00","preferredDefinition":"A carcinoid tumor characterized by a high mitotic rate, often associated with the presence of necrosis and nuclear pleomorphism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neuroendocrine Tumor G2","conceptCode":"C72074","definition":"A well-differentiated, intermediate-grade epithelial neoplasm with neuroendocrine differentiation. It usually arises from the digestive system, lung, and head and neck.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D654-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-02","modifiedBy":"KUMMEROA","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6A49CC4-F9C5-454C-E053-4EBD850A4E2E","beginDate":"2004-01-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"Lymphoepithelial carcinoma","valueDescription":"Lymphoepithelial carcinoma","ValueMeaning":{"publicId":"2567912","version":"1","preferredName":"Lymphoepithelial carcinoma","longName":"2567912","preferredDefinition":"Lymphoepithelial carcinoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D655-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-02","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6A49CC4-F9CF-454C-E053-4EBD850A4E2E","beginDate":"2004-01-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"Undifferentiated carcinoma","valueDescription":"Undifferentiated carcinoma","ValueMeaning":{"publicId":"2567189","version":"1","preferredName":"Undifferentiated carcinoma","longName":"2567189","preferredDefinition":"Undifferentiated carcinoma","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Undifferentiated Carcinoma","conceptCode":"C3692","definition":"A usually aggressive malignant epithelial neoplasm composed of atypical cells which do not display evidence of glandular, squamous, or transitional cell differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D382-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6A49CC4-F9D9-454C-E053-4EBD850A4E2E","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2575365","version":"1","preferredName":"Unknown","longName":"2575365","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F372-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6A49CC4-F9E3-454C-E053-4EBD850A4E2E","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2559653","version":"1","preferredName":"Other","longName":"2559653","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B612-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6A49CC4-F9ED-454C-E053-4EBD850A4E2E","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"Nonkeratinizing Carcinoma Undifferentiated","valueDescription":"Nasopharyngeal Nonkeratinizing Carcinoma Undifferentiated","ValueMeaning":{"publicId":"3913303","version":"1","preferredName":"Nasopharyngeal Nonkeratinizing Carcinoma Undifferentiated","longName":"3913303","preferredDefinition":"A nasopharyngeal carcinoma characterized by the lack of keratinization and the presence of a dense lymphoplasmacytic infiltrate.  It is subdivided into undifferentiated and differentiated types, based on the cytologic features of the malignant cells.  The undifferentiated type is characterized by the presence of cells with large vesicular nuclei with prominent nucleoli and a syncytial pattern of growth.  The differentiated type is characterized by the presence of smaller cells and cellular stratification reminiscent of transitional cell carcinoma.  While morphologically distinct, both types have similar clinical presentation and prognosis.: A term used to describe cells or tissues that do not have specialized (\"mature\") structures or functions. Undifferentiated cancer cells often grow and spread quickly.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nasopharyngeal Non-Keratinizing Carcinoma","conceptCode":"C7373","definition":"A nasopharyngeal carcinoma characterized by the lack of keratinization and the presence of a dense lymphoplasmacytic infiltrate.  It is subdivided into undifferentiated and differentiated types, based on the cytologic features of the malignant cells.  The undifferentiated type is characterized by the presence of cells with large vesicular nuclei with prominent nucleoli and a syncytial pattern of growth.  The differentiated type is characterized by the presence of smaller cells and cellular stratification reminiscent of transitional cell carcinoma.  While morphologically distinct, both types have similar clinical presentation and prognosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Undifferentiated","conceptCode":"C14176","definition":"Describes tumor cells that generally have lost all of the appearance of normal cells. They tend to grow and spread quickly and aggressively.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7C63677-7C33-0BBB-E040-BB89AD43564C","latestVersionIndicator":"Yes","beginDate":"2013-10-02","endDate":null,"createdBy":"RUETERJ","dateCreated":"2013-10-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6A49CC4-FACE-454C-E053-4EBD850A4E2E","beginDate":"2013-10-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"Squamous Cell Carcinoma","valueDescription":"Squamous Cell Carcinoma","ValueMeaning":{"publicId":"2567412","version":"1","preferredName":"Squamous Cell Carcinoma","longName":"2567412","preferredDefinition":"A carcinoma derived from stratified squamous epithelium. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Squamous Cell Carcinoma","conceptCode":"C2929","definition":"A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D461-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-12-10","modifiedBy":"CLOHNES","dateModified":"2023-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6A49CC4-FA01-454C-E053-4EBD850A4E2E","beginDate":"2010-08-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"High-grade adenocarcinoma","valueDescription":"high-grade adenocarcinoma","ValueMeaning":{"publicId":"3253077","version":"1","preferredName":"high-grade adenocarcinoma","longName":"3253077","preferredDefinition":"high-grade adenocarcinoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7F95BCC-43E7-F720-E040-BB89AD432FA4","latestVersionIndicator":"Yes","beginDate":"2011-07-13","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-07-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6A49CC4-FA0B-454C-E053-4EBD850A4E2E","beginDate":"2011-07-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"High-grade mucoepidermoid carcinoma","valueDescription":"high-grade mucoepidermoid carcinoma","ValueMeaning":{"publicId":"3253078","version":"1","preferredName":"high-grade mucoepidermoid carcinoma","longName":"3253078","preferredDefinition":"high-grade mucoepidermoid carcinoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7F95BCC-440A-F720-E040-BB89AD432FA4","latestVersionIndicator":"Yes","beginDate":"2011-07-13","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-07-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6A49CC4-FA15-454C-E053-4EBD850A4E2E","beginDate":"2011-07-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"Squamous cell carcinoma keratinizing","valueDescription":"Squamous cell carcinoma keratinizing","ValueMeaning":{"publicId":"2567897","version":"1","preferredName":"Squamous cell carcinoma keratinizing","longName":"2567897","preferredDefinition":"Squamous cell carcinoma keratinizing","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D646-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-02","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6A49CC4-FAEC-454C-E053-4EBD850A4E2E","beginDate":"2004-01-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"Squamous cell carcinoma non-keratinizing","valueDescription":"Squamous cell carcinoma non-keratinizing","ValueMeaning":{"publicId":"2567898","version":"1","preferredName":"Squamous cell carcinoma non-keratinizing","longName":"2567898","preferredDefinition":"Squamous cell carcinoma non-keratinizing","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D647-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-02","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6A49CC4-FAF6-454C-E053-4EBD850A4E2E","beginDate":"2004-01-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"Papillary Squamous Cell Carcinoma","valueDescription":"Papillary Squamous Cell Carcinoma","ValueMeaning":{"publicId":"3088108","version":"1","preferredName":"Papillary Squamous Cell Carcinoma","longName":"3088108","preferredDefinition":"A well differentiated squamous cell carcinoma characterized by a papillary, exophytic growth pattern and hyperkeratosis. The most commonly affected anatomic sites are the larynx, penis, cervix, vagina, and vulva.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary Squamous Cell Carcinoma","conceptCode":"C4102","definition":"A well differentiated squamous cell carcinoma characterized by a papillary, exophytic growth pattern and hyperkeratosis. The most commonly affected anatomic sites are the larynx, penis, cervix, vagina, and vulva.","evsSource":"RADLEX_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86E20578-E7EE-8876-E040-BB89AD434ED8","latestVersionIndicator":"Yes","beginDate":"2010-05-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6A49CC4-FA33-454C-E053-4EBD850A4E2E","beginDate":"2014-05-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"Basal cell adenocarcinoma","valueDescription":"Salivary Gland Basal Cell Adenocarcinoma","ValueMeaning":{"publicId":"5053392","version":"1","preferredName":"Salivary Gland Basal Cell Adenocarcinoma","longName":"5053392","preferredDefinition":"A rare adenocarcinoma of the major and minor salivary glands, originating from basaloid, myoepithelial and ductal cells.  While morphologically resembling basal cell carcinomas, it is a distinct entity.  The tumor is not encapsulated, may invade locally, and less frequently may metastasize.  It usually occurs in older patients.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Salivary Gland Basal Cell Adenocarcinoma","conceptCode":"C3678","definition":"A rare adenocarcinoma of the major and minor salivary glands, originating from basaloid, myoepithelial and ductal cells.  While morphologically resembling basal cell carcinomas, it is a distinct entity.  The tumor is not encapsulated, may invade locally, and less frequently may metastasize.  It usually occurs in older patients.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"253E0DBD-46A1-EA96-E050-BB89AD434FF8","latestVersionIndicator":"Yes","beginDate":"2015-11-23","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2015-11-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6A49CC4-FA3D-454C-E053-4EBD850A4E2E","beginDate":"2015-11-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"Carcinoma ex pleomorphic adenoma","valueDescription":"Carcinoma ex Pleomorphic Adenoma","ValueMeaning":{"publicId":"5053393","version":"1","preferredName":"Carcinoma ex Pleomorphic Adenoma","longName":"5053393","preferredDefinition":"A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.: An operation in which a term denies or inverts the meaning of another term or construction.: Being or existing in a specified place or at the specified time.: A neoplasm characterized by the presence of benign epithelial and myoepithelial cells and a mesenchymal component that may contain mucoid, myxoid, cartilaginous, or osseous areas. It may be completely or partially encapsulated. It occurs in the parotid gland, submandibular gland, minor salivary glands in the oral cavity, upper respiratory tract, and nasal cavity and paranasal sinuses. It usually presents as a slow growing painless mass. Infrequently, patients may present with pain and facial palsy. It may recur after excision or transform to a malignant neoplasm (carcinoma ex pleomorphic adenoma).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Carcinoma","conceptCode":"C2916","definition":"A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Pleomorphic Adenoma","conceptCode":"C8602","definition":"A neoplasm characterized by the presence of benign epithelial and myoepithelial cells and a mesenchymal component that may contain mucoid, myxoid, cartilaginous, or osseous areas. It may be completely or partially encapsulated. It occurs in the parotid gland, submandibular gland, minor salivary glands in the oral cavity, upper respiratory tract, and nasal cavity and paranasal sinuses. It usually presents as a slow growing painless mass. Infrequently, patients may present with pain and facial palsy. It may recur after excision or transform to a malignant neoplasm (carcinoma ex pleomorphic adenoma).","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"253E0DBD-46C9-EA96-E050-BB89AD434FF8","latestVersionIndicator":"Yes","beginDate":"2015-11-23","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2015-11-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6A49CC4-FA47-454C-E053-4EBD850A4E2E","beginDate":"2015-11-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"Adenocarcinoma Not Otherwise Specified (NOS)","valueDescription":"Adenocarcinoma Not Otherwise Specified","ValueMeaning":{"publicId":"3536361","version":"1","preferredName":"Adenocarcinoma Not Otherwise Specified","longName":"3536361","preferredDefinition":"A common cancer characterized by the presence of malignant glandular cells. Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous). Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.: Not characterized in any other way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C60C12FE-0E35-1D09-E040-BB89AD434D85","latestVersionIndicator":"Yes","beginDate":"2012-07-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-07-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6A49CC4-FA51-454C-E053-4EBD850A4E2E","beginDate":"2015-11-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"Not specified","valueDescription":"Unspecified","ValueMeaning":{"publicId":"5697867","version":"1","preferredName":"Unspecified","longName":"5697867","preferredDefinition":"Not stated explicitly or in detail.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unspecified","conceptCode":"C38046","definition":"Not stated explicitly or in detail.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A23568A-7798-5975-E053-F662850A8E6C","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-03-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6A49CC4-FA5B-454C-E053-4EBD850A4E2E","beginDate":"2018-03-08","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"},{"value":"Nonkeratinizing poorly differentiated","valueDescription":"Nasopharyngeal Nonkeratinizing Carcinoma Poorly Differentiated","ValueMeaning":{"publicId":"7297636","version":"1","preferredName":"Nasopharyngeal Nonkeratinizing Carcinoma Poorly Differentiated","longName":"7297636","preferredDefinition":"A nasopharyngeal carcinoma characterized by the lack of keratinization and the presence of a dense lymphoplasmacytic infiltrate.  It is subdivided into undifferentiated and differentiated types, based on the cytologic features of the malignant cells.  The undifferentiated type is characterized by the presence of cells with large vesicular nuclei with prominent nucleoli and a syncytial pattern of growth.  The differentiated type is characterized by the presence of smaller cells and cellular stratification reminiscent of transitional cell carcinoma.  While morphologically distinct, both types have similar clinical presentation and prognosis.: Describes tumor cells that generally have lost most of the appearance of normal cells. They tend to grow and spread.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nasopharyngeal Non-Keratinizing Carcinoma","conceptCode":"C7373","definition":"A nasopharyngeal carcinoma characterized by the lack of keratinization and the presence of a dense lymphoplasmacytic infiltrate.  It is subdivided into undifferentiated and differentiated types, based on the cytologic features of the malignant cells.  The undifferentiated type is characterized by the presence of cells with large vesicular nuclei with prominent nucleoli and a syncytial pattern of growth.  The differentiated type is characterized by the presence of smaller cells and cellular stratification reminiscent of transitional cell carcinoma.  While morphologically distinct, both types have similar clinical presentation and prognosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Poorly Differentiated","conceptCode":"C14167","definition":"Describes tumor cells that generally have lost most of the appearance of normal cells. They tend to grow and spread.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A693B644-47C2-49E4-E053-4EBD850AB12E","latestVersionIndicator":"Yes","beginDate":"2020-05-26","endDate":null,"createdBy":"PATELV","dateCreated":"2020-05-26","modifiedBy":"ONEDATA","dateModified":"2020-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A6A49CC4-FA65-454C-E053-4EBD850A4E2E","beginDate":"2020-05-26","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-05-27","modifiedBy":"ONEDATA","dateModified":"2020-05-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2208105","version":"1","preferredName":"Histologic Category","preferredDefinition":"Of or relating to histology.:Category; used informally to mean a class of things.","longName":"C25526:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-3D9A-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6A49CC4-F8F0-454C-E053-4EBD850A4E2E","latestVersionIndicator":"Yes","beginDate":"2020-05-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-05-27","modifiedBy":"CAMPBELB","dateModified":"2020-05-27","changeDescription":"Removed commas from PVs.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811912","version":"1","longName":"Head and Neck","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"10000369","version":"1","longName":"Curative Head/Neck","context":"CTEP"},{"publicId":"10000614","version":"1","longName":"Palliative Head/Neck","context":"CTEP"}]},{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2811715","version":"1","longName":"Duke University","context":"NCIP"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4171051","version":"1","longName":"RTOG-1016","context":"NRG"},{"publicId":"4104934","version":"1","longName":"RTOG-1216","context":"NRG"},{"publicId":"4104935","version":"1","longName":"RTOG-1221","context":"NRG"},{"publicId":"4171052","version":"1","longName":"RTOG-0920","context":"NRG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Histologic Type","type":"Preferred Question Text","description":"Histologic Type","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Histologic subtype","url":null,"context":"Alliance"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A6A4A217-497A-4C13-E053-4EBD850A10C9","latestVersionIndicator":"Yes","beginDate":"2020-05-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-05-27","modifiedBy":"GDEEN","dateModified":"2022-07-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}